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1726 Abstracts December 2014was developed from this group yielded the following independent predictors
of operative groin wound infection: previous groin incision, female gender,
body mass index, end-stage renal disease, malnutrition, and urgent/emer-
gency operation status. The C index of the resulting model was 0.845
and resulted in a correct classiﬁcation of 88.6% of patients. Subsequent
testing in the validation group (13.9% of whom sustained an operative groin
wound infection) yielded an accuracy of 86.1% for our predictive model. We
therefore developed a user-friendly computer program, which will be pub-
licly accessible, that can be used to calculate an individual patient’s risk of
developing operative groin wound infection after lower extremity revascu-
larization (Fig).
Conclusions: Our study is the ﬁrst known attempt to develop and
internally validate a statistical model that will accurately predict those pa-
tients who are likely to sustain an operative groin wound infection after
lower extremity revascularization.Fig. Risk calculator for postoperative groin wound infection.Author Disclosures: K. M. Bennett: None; H. Levinson: None; J. E.
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Introduction: Endothermal heat-induced thrombosis (EHIT) of the
common femoral vein or popliteal vein can occur after endovenous laser abla-
tion (EVLA) of the saphenous veins. We have previously reported an inci-
dence of 5.1% and identiﬁed that a vein diameter of $7.5 mm increased the
risk of EHIT after EVLA using an 810-nm wavelength laser. The impact of
laser wavelength on EHIT has not been previously evaluated, and we hypoth-
esized that the incidence of EHIT would depend on the laser wavelength.
Methods: We identiﬁed patients having EVLA in our ofﬁce from
2005-2014 with a 810-nm (hemoglobin-speciﬁc) or 1470-nm (water-spe-
ciﬁc) laser. We reviewed the records for age, gender, body mass index,
CEAP class, vein(s) treated, adjunctive phlebectomy, energy delivered,
EHIT (level $3) development, treatment and course. The Fisher exact test
and Pearson c2 were used to evaluate the association between deep venous
thrombosis (DVT) and the categoric variables. Logistic regression was used
to evaluate the relationship between DVT and the continuous variables.
Results: There were 1456 veins ablated in 1118 patients (775 female,
343 male). The great saphenous vein (GSV) was treated in 1337, the small
saphenous vein (SSV) in 77, and both were treated in 20 (22 procedures on
accessory veins were excluded). The CEAP class for these patients was 1 (0),
2 (618), 3 (521), 4 (148), 5 (50), 6 (95) and not recorded in 2. EHIT
occurred in 71 cases (4.95%), 68 after GSV ablation and three after SSV
ablation. The 810-nm laser was used in 1142, and 64 (5.6%) developed
EHIT. The 1470-nm laser was used in 292, with seven (2.4%) developing
EHIT (P ¼ .0229 by Fisher exact test). The average energy delivered to the
EHIT group (3475 6 1941 joules) was higher than for the non-EHIT
group (2866 6 1475 joules; P ¼ .0012). The average vein diameter was
higher in the EHIT group (9.3 6 3.9 mm) than in the non-EHIT group
(7.2 6 3.2 mm; P ¼ .0001). EHIT occurred in 55 of 836 patients
(6.17%) having simultaneous stab phlebectomy compared with 16 of 527
(2.95%) of patients having only EVLA (P ¼ .0057). Statistical analysisconﬁrmed there is signiﬁcant association between DVT and CEAP class
(P ¼ .0001). No differences were seen for age, body mass index, gender,
anticoagulation use, combined bilateral procedures, or simultaneous GSV
and SSV ablations between the two groups. EHIT in the femoral vein
was at level 3 (22), 4 (18), 5 (17), and 6 (14), and treatment for the
EHIT consisted of observation, anticoagulation, or antiplatelet therapy.
Duration of therapy was usually brief. No pulmonary emboli occurred in
any of these patients, and EHIT resolved completely in all.
Conclusions: This study shows that a water-speciﬁc laser ﬁber wave-
length (1470 nm) reduces the risk of EHIT compared with a hemoglobin-
speciﬁc wavelength (810 nm). It also demonstrates that CEAP class,
increased energy delivery, simultaneous phlebectomy, and increased vein
diameter are associated with increased risk of EHIT after EVLA.
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Introduction: Ischemic steal syndrome (ISS) is a dreaded complica-
tion after hemodialysis access creation. Its management is complex and var-
ied, with most requiring surgical revision for correction of symptoms.
Revision using distal inﬂow (RUDI) has been described in small series for
the treatment of ISS. We present our experience with RUDI for the treat-
ment of ISS and pathologic high ﬂow (HF).
Methods: We retrospectively reviewed consecutive patients who un-
derwent RUDI for ISS from April 2010 to March 2014. Data collection
included demographics, medical histories, subsequent procedures, volume
ﬂows, access usage, limb salvage, and patient survival.
Results: We performed 32 RUDI procedures in 31 patients (18
women, 13 men). Indications for surgery were pathologic HF in 15 and
ISS in 21. Sixteen percent had prior plication for ISS or HF. Seventy-one
percent of patients had a history of diabetes, and 52% had a history of
atherosclerotic disease. Time to intervention from creation was 40 months
(range, 6-88 months). Accesses included one upper arm graft and 30
brachial artery-based ﬁstulas. Outﬂow included 26 cephalic veins and four
basilic veins. Distalization targets were 20 radial arteries, nine ulnar arteries,
and three distal brachial arteries. Mean ﬂow reduction was 994 mL/min.
Primary assisted patency at 1 year was 73%, and secondary patency was
88%. The RUDI in one patient was revised from a distal brachial to radial
inﬂow. A single access was ligated for continued heart failure after RUDI.
ISS symptom resolution was reported as complete in 81% and partial in 19%.
Conclusions: RUDI is an effective and lasting treatment of ISS and
HF and comparable to reported experiences with distal revascularization-in-
terval ligation, proximalization of the arterial inﬂow, and plication. Patient
selection is key for optimizing relief of symptoms and maintaining use of
the access.
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Introduction: Initiatives to develop patient-centered approaches to
health care are a priority that may have profound effects on health care, partic-
ularlywithin value-basedpurchasing and risk-sharingmodels. Patient-centered
care requires more direct engagement of patients in their own care, including
treatment decisions. Patient participation in treatment selection for vascular
procedures has not been characterized, and the potential effects of greater pa-
tient involvement are unknown.We conducted a prospective study among pa-
tients undergoing vascular procedures to identify important sources of
information and characterize experienced vs desired decision-making roles.
Methods: Patients undergoing elective vascular procedures were
identiﬁed from an outpatient clinic and vascular laboratory. An instrument
consisting of multiple choice and open-ended response items related to pa-
tients’ roles in decision making, sources of information, and perceived treat-
ment success was administered. Diagnostic, demographic, and educational
data were collected. Descriptive statistics are presented as count (%) for
